A Phase II Evaluation of a 3-Drug Combination of Cyclophosphamide, Doxorubicin and 5-Fluorouracil and of 5-Fluorouracil in Patients with Advanced Bladder Carcinoma or Stage D Prostatic Carcinoma-Reference-Cited by-同舟云学术

A Phase II Evaluation of a 3-Drug Combination of Cyclophosphamide, Doxorubicin and 5-Fluorouracil and of 5-Fluorouracil in Patients with Advanced Bladder Carcinoma or Stage D Prostatic Carcinoma

Published:1981-02 Issue:2 Volume:125 Page:191-195
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Smalley R.V.¹²,Bartolucci A.A.¹²,Hemstreet G.¹²,Hester M.¹²

Affiliation:

1. From the Department of Medicine, Temple University School of Medicine, Philadelphia, Pennsylvania

2. Departments of Biostatistics and Urology, University of Alabama School of Medicine, Birmingham, Alabama

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. The chemotherapy of advanced bladder cancer;deKernion;Cancer Res.,1977

2. The continued evaluation of the effects of chemotherapy in patients with advanced carcinoma of the prostate;Scott;J. Urol.,1976

3. Comparison of adriamycin (adria) and 5-fluorouracil (5 FU) in advanced prostatic cancer;DeWys;Abstract. Proc. Amer. Ass. Cancer Res.,1978

4. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin;Merrin;J. Urol.,1976

5. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial;Chlebowski;Cancer,1978

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Hydrocotyle sibthorpioides extract on transplanted tumors and immune function in mice;Phytomedicine;2007-02

2. IRL-1620, a tumor selective vasodilator, augments the uptake and efficacy of chemotherapeutic agents in prostate tumor rats;The Prostate;2007

3. Chemotherapy for hormone-refractory prostate cancer;Cochrane Database of Systematic Reviews;2006-10-18

4. Non-hormonal systemic therapy in men with hormone-refractory prostate cancer and metastases: a systematic review from the Cancer Care Ontario Program in Evidence-based Care's Genitourinary Cancer Disease Site Group;BMC Cancer;2006-05-02

5. Chemotherapy for Metastatic Bladder Cancer;Clinical Oncology;2005-10